Korro Bio, Inc.’s Post

Last week, Korro Bio participated in the 6th Annual #RNAEditingSummit in Boston, where industry leaders gathered to discuss the latest scientific developments in RNA editing. Our CEO and President, Ram Aiyar, Ph.D., joined a fireside panel to discuss the breakthroughs and challenges shaping RNA editing. Ram spoke about the foundational work that has brought us to the present moment where Korro’s long-term goal is developing RNA editing therapeutics that generate functional protein variants.   Venkat Krishnamurthy, Ph.D., Senior Vice President, Head of Platform, also shared insights reinforcing the precision and versatility of our OPERA® platform. Thank you to the World RNA Events Series and fellow participants for facilitating these important conversations. #RNAEditing #RNATherapies #RNATherapeutics